Gene-gene interactions in breast cancer susceptibility
- PMID: 22072393
- PMCID: PMC4125627
- DOI: 10.1093/hmg/ddr525
Gene-gene interactions in breast cancer susceptibility
Abstract
There have been few definitive examples of gene-gene interactions in humans. Through mutational analyses in 7325 individuals, we report four interactions (defined as departures from a multiplicative model) between mutations in the breast cancer susceptibility genes ATM and CHEK2 with BRCA1 and BRCA2 (case-only interaction between ATM and BRCA1/BRCA2 combined, P = 5.9 × 10(-4); ATM and BRCA1, P= 0.01; ATM and BRCA2, P= 0.02; CHEK2 and BRCA1/BRCA2 combined, P = 2.1 × 10(-4); CHEK2 and BRCA1, P= 0.01; CHEK2 and BRCA2, P= 0.01). The interactions are such that the resultant risk of breast cancer is lower than the multiplicative product of the constituent risks, and plausibly reflect the functional relationships of the encoded proteins in DNA repair. These findings have important implications for models of disease predisposition and clinical translation.
Similar articles
-
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.Breast Cancer Res. 2007;9(2):R27. doi: 10.1186/bcr1669. Breast Cancer Res. 2007. PMID: 17428325 Free PMC article.
-
Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility.Hum Mol Genet. 2007 May 1;16(9):1051-7. doi: 10.1093/hmg/ddm050. Epub 2007 Mar 6. Hum Mol Genet. 2007. PMID: 17341484
-
[The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic].Klin Onkol. 2012;25 Suppl:S59-66. Klin Onkol. 2012. PMID: 22920209 Review. Czech.
-
The genetic epidemiology of breast cancer genes.J Mammary Gland Biol Neoplasia. 2004 Jul;9(3):221-36. doi: 10.1023/B:JOMG.0000048770.90334.3b. J Mammary Gland Biol Neoplasia. 2004. PMID: 15557796 Review.
-
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832. Breast Cancer Res. 2011. PMID: 21356067 Free PMC article.
Cited by
-
Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk.Genet Epidemiol. 2016 Jul;40(5):425-31. doi: 10.1002/gepi.21971. Epub 2016 Apr 25. Genet Epidemiol. 2016. PMID: 27112364 Free PMC article.
-
Management of familial cancer: sequencing, surveillance and society.Nat Rev Clin Oncol. 2014 Dec;11(12):723-31. doi: 10.1038/nrclinonc.2014.169. Epub 2014 Oct 14. Nat Rev Clin Oncol. 2014. PMID: 25311347 Review.
-
CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer.Eur J Hum Genet. 2014 Jan;22(1):46-51. doi: 10.1038/ejhg.2013.85. Epub 2013 May 8. Eur J Hum Genet. 2014. PMID: 23652375 Free PMC article.
-
Properties of local interactions and their potential value in complementing genome-wide association studies.PLoS One. 2013 Aug 5;8(8):e71203. doi: 10.1371/journal.pone.0071203. Print 2013. PLoS One. 2013. PMID: 23940718 Free PMC article.
-
Gene network inference by fusing data from diverse distributions.Bioinformatics. 2015 Jun 15;31(12):i230-9. doi: 10.1093/bioinformatics/btv258. Bioinformatics. 2015. PMID: 26072487 Free PMC article.
References
-
- Strange A., Capon F., Spencer C.C., Knight J., Weale M.E., Allen M.H., Barton A., Band G., Bellenguez C., Bergboer J.G., et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 2010;42:985–990. doi: 10.1038/ng.694. - DOI - PMC - PubMed
-
- Antoniou A.C., Sinilnikova O.M., McGuffog L., Healey S., Nevanlinna H., Heikkinen T., Simard J., Spurdle A.B., Beesley J., Chen X., et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum. Mol. Genet. 2009;18:4442–4456. doi: 10.1093/hmg/ddp372. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 068545/Z/02/WT_/Wellcome Trust/United Kingdom
- C1287/A8874/CRUK_/Cancer Research UK/United Kingdom
- 15106/CRUK_/Cancer Research UK/United Kingdom
- 090532/WT_/Wellcome Trust/United Kingdom
- C8620/A8372/CRUK_/Cancer Research UK/United Kingdom
- 11022/CRUK_/Cancer Research UK/United Kingdom
- C1287/A10118/CRUK_/Cancer Research UK/United Kingdom
- G0000934/MRC_/Medical Research Council/United Kingdom
- 10118/CRUK_/Cancer Research UK/United Kingdom
- G0700491/MRC_/Medical Research Council/United Kingdom
- C8620/A8857/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous